Topical aprepitant in clinical and experimental pruritus

Arch Dermatol. 2012 Aug;148(8):957-9. doi: 10.1001/archdermatol.2012.1018.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Administration, Cutaneous
  • Adult
  • Aged
  • Aged, 80 and over
  • Antiemetics / pharmacology
  • Antiemetics / therapeutic use*
  • Aprepitant
  • Double-Blind Method
  • Female
  • Histamine / adverse effects
  • Humans
  • Male
  • Middle Aged
  • Morpholines / pharmacology
  • Morpholines / therapeutic use*
  • Neurokinin-1 Receptor Antagonists
  • Pruritus / chemically induced
  • Pruritus / drug therapy*
  • Severity of Illness Index
  • Water Loss, Insensible / drug effects

Substances

  • Antiemetics
  • Morpholines
  • Neurokinin-1 Receptor Antagonists
  • Aprepitant
  • Histamine